Jefferies Raises Price Target on Athenahealth (ATHN) to $110

October 14, 2016 9:05 AM EDT
Get Alerts ATHN Hot Sheet
Price: $108.37 -4.06%

Rating Summary:
    16 Buy, 12 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 23 | New: 30
Trade ATHN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Jefferies reiterated an Underperform rating on Athenahealth (NASDAQ: ATHN), and raised the price target to $110.00 (from $105.00), ahead of the company's 3Q earnings report.

Analyst Sean Dodge commented, "Bookings performance YTD has been tepid, making 3Q an important indicator of the '17 targets ATHN will set at its 12/15 I-day. Upside to 3Q 'doc adds' is likely, but absent another large Enterprise deal (or strong Small/Group bookings), we see topline growth decelerating further in 2017. Slowing revenue growth is likely accompanied by further multiple compression."

For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.

Shares of athenahealth closed at $126.34 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Jefferies & Co, Earnings

Add Your Comment